Total Funding
48
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 48 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
- Mary Janatpour: Chief Scientific OfficerPast Role: Spotlight Therapeutics, Senior Vice President of Biology
- Hari Jayaram: VP of Technology
About the Company
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
Women Led
